Table 3.
Univariate | Multivariate | |||
---|---|---|---|---|
Variables | HR (95% CI) | p value | HR (95% CI) | p value |
Age (years) | ||||
≤ 10 | Reference | < 0.001*** | Reference | < 0.001*** |
11–20 | 1.873 (1.388–2.528) | < 0.001*** | 1.549(1.144–2.099) | 0.005** |
21–30 | 2.351 (1.674–3.301) | < 0.001*** | 1.808(1.278–2.556) | 0.001** |
31–49 | 3.494 (2.410–5.064) | < 0.001*** | 3.481(2.379–5.094) | < 0.001*** |
≥ 50 | 4.557 (2.831–7.336) | < 0.001*** | 4.307 (2.648–7.006) | < 0.001*** |
Gender | ||||
Male | Reference | |||
Female | 0.905 (0.746–1.099) | 0.313 | ||
Race | ||||
White | Reference | 0.008** | Reference | 0.011* |
Black | 2.120 (1.321–3.403) | 0.002** | 2.104 (1.296–3.416) | 0.003** |
Other | 1.025 (0.715–1.469) | 0.894 | 1.107 (0.706–1.465) | 0.928 |
Primary site | ||||
Limb | Reference | < 0.001*** | Reference | 0.004** |
Cranial | 1.139 (0.730–1.778) | 0.566 | 1.480 (0.922–2.377) | 0.104 |
Spine | 1.478 (1.034–2.111) | 0.032* | 1.458 (0.999–2.129) | 0.051 |
Thoracic | 1.062 (0.796–1.418) | 0.681 | 0.909 (0.675–1.226) | 0.532 |
Pelvic | 1.855 (1.493–2.305) | < 0.001*** | 1.462 (1.151–1.858) | 0.002** |
Tumor size (cm) | ||||
< 5 | Reference | < 0.001*** | Reference | < 0.001*** |
5–8 | 1.395 (1.025–1.898) | 0.034* | 1.386 (1.005–1.911) | 0.046* |
> 8 | 1.985 (1.493–2.640) | < 0.001*** | 1.877 (1.376–2.561) | < 0.001*** |
Tumor extent | ||||
Localized | Reference | < 0.001*** | Reference | < 0.001*** |
Regional | 1.512(1.148–1.991) | 0.003* | 1.373 (1.033–1.823) | 0.029* |
Metastatic | 3.820(2.897–5.038) | < 0.001*** | 3.259 (2.425–4.379) | < 0.001*** |
Cancer-directed surgery | ||||
No | Reference | Reference | ||
Yes | 0.571 (0.473–0.690) | < 0.001*** | 0.933 (0.749–1.172) | 0.536 |
Radiation | ||||
No | Reference | Reference | ||
Yes | 1.352 (1.122–1.630) | 0.002** | 1.065 (0.874–1.299) | 0.531 |
Chemotherapy | ||||
No | Reference | Reference | ||
Yes | 0.426 (0.282–0.642) | < 0.001*** | 0.466 (0.290–0.685) | < 0.001*** |
p value < 0.05*, < 0.01**, < 0.001***